GLOBAL BETA GLUCAN MARKET FORECAST 2018-2026

  • You are here:
  • Home
  • Reports
  • GLOBAL BETA GLUCAN MARKET FORECAST 2018-2026

GLOBAL BETA GLUCAN MARKET FORECAST 2018-2026

Global Beta glucan market is estimated to grow with approx.7.47% CAGR during the year 2018 – 2026. The base year considered for the study is 2017 and the forecast period is between 2018-2026. Global Beta glucan market is primarily driven by the following factors: Growing health concern among consumers and increasing health expenditure. Growing applications of beta-glucan in the food industry

GLOBAL BETA GLUCAN MARKET FORECAST 2018-2026

Global Beta Glucan Market by Source (Bacteria, Fungus, Yeast, Cereal, Algae) by End-users (Food and Beverages, Personal Care, Pharmaceuticals, Animal Feed)  by Category (Insoluble Beta Glucan, Soluble Beta Glucan) by Geography

Request free sample

Global Beta glucan market is estimated to grow with approx.7.47% CAGR during the year 2018 – 2026. The base year considered for the study is 2017 and the forecast period is between 2018-2026. Global Beta glucan market is primarily driven by the following factors:

  • Growing health concern among consumers and increasing health expenditure
  • Growing applications of beta-glucan in the food industry
  • Decreasing prices of major raw material sources

The important driver increasing growth in the global beta glucan market is the growing health concern among consumers and increasing health expenditure. Health concerns among consumers are growing due to rise in diabetes, cancer and other diseases and beta glucan is helpful in the treatment of such diseases. Beta glucan has potential application in reducing cholesterol, glucose and insulin level. Dietary intake of beta-glucan can help in reducing risk factors for diabetes. It is also applied to the skin for bedsores, diabetic ulcers, eczema, dermatitis and radiation burns. Moreover, the rise in healthcare expenditure across the globe is expected to boost the beta glucan market globally.

Beta glucans have potential immune stimulatory properties and are being used with a therapeutic intent as anti-tumour and anti-microbial agents. Beta glucans are currently being used for the treatment of a range of diseases including cancer, diabetes, high cholesterol, HIV/AIDS and the diseases related to a weakened immune system. They are widely available online and over-the-counter. The growth of pharmaceuticals market for beta glucans is driven by the high prevalence of diseases such as cancer, diabetes, AIDS etc. Cancer is amongst the leading causes of death across the world.

Various side effects of consuming beta glucan and inconsistency in regulatory norms are the major factors hindering the beta glucan market. According to National Center for Biotechnology Information (NCBI), Beta-glucans are more likely to be safe when taken by mouth in an amount commonly found in foods. However, there are some restriction and side effects of beta-glucan when taken by injection. These include chills, pain at the injection site, vomiting, high or low blood pressure, nausea, rashes, decreased number of white blood cells and increased urine. Additionally, as per NCBI, beta glucans when taken by injection that have microparticle are also not safe.

The global beta glucan market segments include source, end-user, and category.

Sources are segmented into:

  • Bacteria
  • Fungus
  • Yeast
  • Cereal
  • Algae

End –users are segmented into:

  • Food & Beverages
  • Personal care
  • Pharmaceuticals
  • Animal feed

Category is segmented into:

  • Insoluble beta glucan
  • Soluble beta glucan

The market report scope is widely characterized on the basis of the category of beta-glucan that includes soluble and insoluble beta-glucan. The total market revenue is restricted to revenues generated from the net adoption of beta-glucan across various end-user vertical and revenues of end-user products that contain beta-glucan as an ingredient has been excluded from the report scope.

Geographically, the Global Beta glucan market has been segmented on the basis of four major regions, which includes:

Europe is anticipated to account for the largest market share during the forecast period owing to the adoption of beta-glucan in the personal care industry and increasing prevalence of diseases such as cholesterol, cancer and others. As per Cosmetics Europe, during 2015, the cosmetics market in Europe was valued at around $xx billion, which makes Europe the biggest cosmetics market globally. Among the countries in Europe, Germany was the leading cosmetic product market during 2015. The cosmetic industry is widely adopting beta glucan in their products for anti-wrinkle skin permeation absorption moisturizing and in other applications. Moreover, increasing product launches, and expansion and other initiatives by the existing companies in the region is also propelling the beta glucan market. On the other hand, North America is anticipated to be the fastest-growing region for the global beta-glucan market. This high growth is attributed to the funding raised by the private organizations, rising prevalence of diseases such as cancer and diabetes, escalating clinical trials related to beta-glucan and strategic initiatives taken by the private organizations. The primary applications of beta-glucan are found in the pharmaceutical sector as it is used in the production of medicines that are used for the treatment of diabetes. It is also used in the treatment of cancer during the procedures of chemotherapy and radiations.

The Beta glucan market is segmented on the basis of sources which are divided into bacteria, fungus, yeast, cereal, algae. The market is also segmented on the basis  of end-users which are sub-divided into food & beverages, personal care, pharmaceuticals, and animal feed.  On the basis of category, the beta-glucan market has been segmented into insoluble beta glucan and soluble beta-glucan.

The major market players in the global beta glucan market are:

  • Cargill Inc (US)
  • Kerry Group Plc (Israel)
  • Koninklijke Dsm N.V.
  • Ohly (Germany)
  • Tate & Lyle (UK)
  • Others

Company Profiles covers analysis of important players

These companies are using organic and inorganic strategies for growth. For instance, in September 2017, Kemin Industries signed a partnership agreement with Valensa International to supply and commercialize BetaVia ingredients, immune-supporting beta-glucans sourced from a proprietary strain of algae (Euglena gracilis), specifically in the U.S. dietary supplement and functional foods & beverages markets. This partnership is likely to help the company to expand its product portfolio to increase its beta-glucan segment revenue. In November 2017, Ohly launched a new product named AUXOFERM HCT, which is an additive for animal feed. This product launch has expanded the product portfolio of the company.

Key Findings of the global beta glucan market.

  • Growing health concerns among consumers and increasing health expenditures are fueling growth in the global beta glucan market.
  • Europe is anticipated to account for the largest revenue share in 2017.
  • Cereal segment is dominating the market
  • Increasing government support
  • Product launch is the key strategy adopted by various market players of the global beta glucan market.
  • Pharmaceuticals sector is a major end-user
  1. RESEARCH SCOPE
    • STUDY GOALS
    • SCOPE OF THE MARKET STUDY
    • WHO WILL FIND THIS REPORT USEFUL?
    • STUDY AND FORECASTING YEARS
  2. RESEARCH METHODOLOGY
    • SOURCES OF DATA
      • SECONDARY DATA
      • PRIMARY DATA
    • TOP DOWN APPROACH
    • BOTTOM-UP APPROACH
    • DATA TRIANGULATION
    • ESTIMATION METHODOLOGY
  3. EXECUTIVE SUMMARY
    • MARKET SUMMARY
    • KEY FINDINGS
      • EUROPE HELD A COLOSSAL SHARE OF THE MARKET
      • UNITED STATES TO WITNESS ROBUST GROWTH DURING THE FORECAST PERIOD
      • PHARMACEUTICAL- MAJOR MARKET BY END-USER
      • SOLUBLE BETA GLUCAN HELD MAJOR CHUNK OF THE MARKET BY CATEGORY
      • CEREALS TO OFFER LUCRATIVE OPPORTUNITIES
  1. MARKET DYNAMICS
    • MARKET DEFINITION
    • DRIVERS
      • GROWING HEALTH CONCERN AMONG CONSUMERS AND INCREASING HEALTH EXPENDITURE
      • GROWING APPLICATIONS OF BETA-GLUCAN IN FOOD INDUSTRY
      • DECREASING PRICES OF MAJOR RAW MATERIAL SOURCES
    • RESTRAINTS
      • VARIOUS SIDE EFFECTS OF CONSUMING BETA GLUCAN
      • INCONSISTENCY IN REGULATORY NORMS
    • OPPORTUNITIES
      • UNEXPLOITED BETA GLUCAN APPLICATIONS IN COSMETIC AND MEDICINE SECTOR
    • CHALLENGES
      • INCREASE IN COST OF BETA-GLUCAN EXTRACTION PROCESS
  1. MARKET BY SOURCE
    • BACTERIA
    • FUNGUS
    • YEAST
    • CEREAL
    • ALGAE
  2. MARKET BY END-USERS
    • FOOD AND BEVERAGES
    • PERSONAL CARE
    • PHARMACEUTICALS
    • ANIMAL FEED
  3. MARKET BY CATEGORY
    • INSOLUBLE BETA GLUCAN
    • SOLUBLE BETA GLUCAN
  4. KEY ANALYTICS
    • PORTERS 5 FORCE MODEL
      • THREAT OF NEW ENTRANTS
      • THREAT OF SUBSTITUTE PRODUCTS
      • BARGAINING POWER OF BUYERS
      • BARGAINING POWER OF SUPPLIERS
      • INTENSITY OF COMPETITIVE RIVALRY
    • KEY BUYING CRITERIA
      • COST
      • NUTRITIONAL CONTENT
      • SOURCE
      • APPLICATIONS
    • VALUE CHAIN ANALYSIS
      • RAW MATERIAL SUPPLIERS
      • MANUFACTURING
      • DISTRIBUTORS/RETAILERS
      • END-USERS
    • REGULATORY FRAMEWORK
    • KEY TRENDS
      • RISING PREVALENCE OF DIABETES
      • INVESTMENTS IN BETA GLUCAN
    • INVESTMENT OUTLOOK
      • REGIONAL OUTLOOK
      • END-USERS OUTLOOK
    • VENDOR LANDSCAPE
    • OPPORTUNITY MATRIX
  5. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • US
      • CANADA
    • EUROPE
      • UK
      • FRANCE
      • GERMANY
      • ITALY
      • SPAIN
      • REST OF EUROPE
    • ASIA PACIFIC
      • CHINA
      • INDIA
      • JAPAN
      • SOUTH KOREA
      • AUSTRALIA
      • REST OF ASIA PACIFIC
    • REST OF WORLD
      • LATIN AMERICA
      • MIDDLE EAST AND AFRICA
  1. COMPETITIVE LANDSCAPE
    • MARKET SHARE ANALYSIS
      • CARGILL INC (US)
      • TATE & LYLE (UK)
      • KERRY GROUP PLC (ISRAEL)
      • OHLY (GERMANY)
      • KONINKLIJKE DSM N.V. (NETHERLANDS)
    • COMPANY PROFILES
      • ALLTECH BIOTECHNOLOGY
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC ANALYSIS
      • CARGILL INC
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC ANALYSIS
      • HANSEN A/S
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC ANALYSIS
      • GARUDA INTERNATIONAL INC
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC ANALYSIS
      • KEMIN INDUSTRIES
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES
        • SCOT ANALYSIS
        • STRATEGIC ANALYSIS
      • SPECIALTY BIOTECH LTD
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC ANALYSIS
      • MILLIPORESIGMA (MERCK)
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC ANALYSIS
      • OHLY
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES
        • SCOT ANALYSIS
        • STRATEGIC ANALYSIS
      • TATE & LYLE PLC
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES
        • SCOT ANALYSIS
        • STRATEGIC ANALYSIS
      • SUPER BETA GLUCAN
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC ANALYSIS
      • KONINKLIJKE DSM N.V.
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC ANALYSIS
      • FRUTAROM
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC ANALYSIS
      • KERRY GROUP PLC
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC ANALYSIS
        • SCOT ANALYSIS
        • STRATEGIC ANALYSIS
      • LESAFFRE HUMAN CARE
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC ANALYSIS
      • PHARMACON ASA
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES
        • SCOT ANALYSIS
        • STRATEGIC ANALYSIS

 

LIST OF TABLES

TABLE 1 GLOBAL BETA GLUCAN MARKET BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 2 APPLICATIONS OF DIFFERENT BETA GLUCAN IN FOOD PRODUCTION

TABLE 3 GLOBAL BETA GLUCAN MARKET BY SOURCE 2018-2026 ($ MILLION)

TABLE 4 GLOBAL BACTERIA MARKET BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 5 GLOBAL FUNGUS MARKET BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 6 GLOBAL YEAST MARKET BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 7 GLOBAL CEREAL MARKET BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 8 GLOBAL ALGAE MARKET BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 9 GLOBAL BETA GLUCAN MARKET BY END-USERS 2018-2026 ($ MILLION)

TABLE 10 GLOBAL FOOD AND BEVERAGES MARKET BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 11 GLOBAL PERSONAL CARE MARKET BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 12 GLOBAL PHARMACEUTICALS MARKET BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 13 GLOBAL ANIMAL FEED MARKET BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 14 GLOBAL BETA GLUCAN MARKET BY CATEGORY 2018-2026 ($ MILLION)

TABLE 15 GLOBAL INSOLUBLE BETA GLUCAN MARKET BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 16 GLOBAL SOLUBLE BETA GLUCAN MARKET BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 17 INVESTMENTS IN BETA GLUCAN

TABLE 18 GLOBAL BETA GLUCAN MARKET BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 19 NORTH AMERICA BETA GLUCAN MARKET BY COUNTRY ($ MILLION)

TABLE 20 EUROPE BETA GLUCAN MARKET BY COUNTRY 2018-2026 ($ MILLION)

TABLE 21 ASIA PACIFIC BETA GLUCAN MARKET BY COUNTRY 2018-2026 ($ MILLION)

TABLE 22 REST OF WORLD BETA GLUCAN MARKET 2018-2026 ($ MILLION)

LIST OF FIGURES

FIGURE 1 GLOBAL BETA GLUCAN MARKET BY SOURCE 2018-2026 ($ MILLION)

FIGURE 2 EUROPE BETA GLUCAN MARKET 2018-2026 ($ MILLION)

FIGURE 3 UNITED STATES BETA GLUCAN MARKET 2018-2026 ($ MILLION)

FIGURE 4 GLOBAL SOLUBLE BETA GLUCAN MARKET 2018-2026 ($ MILLION)

FIGURE 5 GLOBAL CEREALS MARKET 2018-2026 ($ MILLION)

FIGURE 6 EVOLUTION OF BETA-GLUCAN MARKET

FIGURE 7 GROWING HEALTHCARE EXPENDITURE IN UNITED STATES ($ PER CAPITA)

FIGURE 8 HEALTHCARE SPENDING PER CAPITA IN 2015 AND 2016

FIGURE 9 FUNCTIONAL FOOD AND BEVERAGES SALES IN BRAZIL 2009-2015 ($ BILLION)

FIGURE 10 COMMODITY PRICE INDEX OF WHEAT CROPS

FIGURE 11 EU OAT PRICES IN 2015 (MAJOR COUNTRIES)

FIGURE 12 GLOBAL COSMETICS PRODUCTS MARKET 2015 ($ BILLION)

FIGURE 13 GLOBAL BACTERIA MARKET 2018-2026 ($ MILLION)

FIGURE 14 GLOBAL FUNGUS MARKET 2018-2026 ($ MILLION)

FIGURE 15 GLOBAL YEAST MARKET 2018-2026 ($ MILLION)

FIGURE 16 GLOBAL CEREAL MARKET 2018-2026 ($ MILLION)

FIGURE 17 GLOBAL ALGAE MARKET 2018-2026 ($ MILLION)

FIGURE 18 GLOBAL FOOD AND BEVERAGES MARKET 2018-2026 ($ MILLION)

FIGURE 19 GLOBAL PERSONAL CARE MARKET 2018-2026 ($ MILLION)

FIGURE 20 GLOBAL PHARMACEUTICALS MARKET 2018-2026 ($ MILLION)

FIGURE 21 GLOBAL ANIMAL FEED MARKET 2018-2026 ($ MILLION)

FIGURE 22 GLOBAL INSOLUBLE BETA GLUCAN MARKET 2018-2026 ($ MILLION)

FIGURE 23 GLOBAL SOLUBLE BETA GLUCAN MARKET 2018-2026 ($ MILLION)

FIGURE 24 GLOBAL NUMBER OF ADULTS WITH DIABETES (IN MILLIONS) (2015 & 2040)

FIGURE 25 TOP 10 COUNTRIES WITH NUMBER OF PEOPLE LIVING WITH DIABETES IN MILLION (2015)

FIGURE 26 PERCENTAGE INCREMENT OF DIABETES ACROSS REGIONS (2015 TO 2040)

FIGURE 27 INVESTMENT PROPOSITION FOR GLOBAL BETA GLUCAN MARKET BY REGION – 2017

FIGURE 28 INVESTMENT PROPOSITION FOR GLOBAL BETA GLUCAN MARKET BY END-USERS – 2017

FIGURE 29 UNITED STATES BETA GLUCAN MARKET 2018-2026

FIGURE 30 CANADA BETA GLUCAN MARKET 2018-2026

FIGURE 31 UNITED KINGDOM BETA GLUCAN MARKET 2018-2026 ($ MILLION)

FIGURE 32 FRANCE BETA GLUCAN MARKET 2018-2026 ($ MILLION)

FIGURE 33 GERMANY BETA GLUCAN MARKET 2018-2026 ($ MILLION)

FIGURE 34 ITALY BETA GLUCAN MARKET 2018-2026 ($ MILLION)

FIGURE 35 SPAIN BETA GLUCAN MARKET 2018-2026 ($ MILLION)

FIGURE 36 REST OF EUROPE BETA GLUCAN MARKET 2018-2026 ($ MILLION)

FIGURE 37 CHINA BETA GLUCAN MARKET 2018-2026 ($ MILLION)

FIGURE 38 INDIA BETA GLUCAN MARKET 2018-2026 ($ MILLION)

FIGURE 39 JAPAN BETA GLUCAN MARKET 2018-2026 ($ MILLION)

FIGURE 40 SOUTH KOREA BETA GLUCAN MARKET 2018-2026 ($ MILLION)

FIGURE 41 AUSTRALIA BETA GLUCAN MARKET 2018-2026 ($ MILLION)

FIGURE 42 REST OF APAC BETA GLUCAN MARKET 2018-2026 ($ MILLION)

FIGURE 43 LATIN AMERICA BETA GLUCAN MARKET 2018-2026 ($ MILLION)

FIGURE 44 MIDDLE EAST AND AFRICA BETA GLUCAN MARKET 2018-2026 ($ MILLION)

FIGURE 45 MARKET SHARE ANALYSIS OF TOP COMPANIES IN GLOBAL BETA GLUCAN MARKET – 2017 (%)

  1. MARKET BY SOURCE
    • BACTERIA
    • FUNGUS
    • YEAST
    • CEREAL
    • ALGAE
  2. MARKET BY END-USERS
    • FOOD AND BEVERAGES
    • PERSONAL CARE
    • PHARMACEUTICALS
    • ANIMAL FEED
  3. MARKET BY CATEGORY
    • INSOLUBLE BETA GLUCAN
    • SOLUBLE BETA GLUCAN
  4. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • US
      • CANADA
    • EUROPE
      • UK
      • FRANCE
      • GERMANY
      • ITALY
      • SPAIN
      • REST OF EUROPE
    • ASIA PACIFIC
      • CHINA
      • INDIA
      • JAPAN
      • SOUTH KOREA
      • AUSTRALIA
      • REST OF ASIA PACIFIC
    • REST OF WORLD
      • LATIN AMERICA
      • MIDDLE EAST AND AFRICA

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

Choose License Type

Buy Now